ArticleFrontiers in immunology2021

Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials.

Yimei Que et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.